Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-2-12
pubmed:abstractText
To examine the clinical effectiveness and cost-effectiveness of oral capecitabine for locally advanced and metastatic breast cancer in relation to its licensed indications.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1366-5278
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
iii, xiii-xvi, 1-143
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:14960257-Administration, Oral, pubmed-meshheading:14960257-Antimetabolites, Antineoplastic, pubmed-meshheading:14960257-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:14960257-Breast Neoplasms, pubmed-meshheading:14960257-Cost-Benefit Analysis, pubmed-meshheading:14960257-Deoxycytidine, pubmed-meshheading:14960257-Disease Progression, pubmed-meshheading:14960257-Drug Therapy, Combination, pubmed-meshheading:14960257-Female, pubmed-meshheading:14960257-Fluorouracil, pubmed-meshheading:14960257-Great Britain, pubmed-meshheading:14960257-Humans, pubmed-meshheading:14960257-Neoplasm Metastasis, pubmed-meshheading:14960257-Quality-Adjusted Life Years, pubmed-meshheading:14960257-Randomized Controlled Trials as Topic, pubmed-meshheading:14960257-State Medicine, pubmed-meshheading:14960257-Survival Rate, pubmed-meshheading:14960257-Taxoids, pubmed-meshheading:14960257-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer.
pubmed:affiliation
NHS Centre for Reviews and Dissemination, University of York, UK.
pubmed:publicationType
Journal Article, Comparative Study, Review